Neuroleptic malignant syndrome vs serotonin syndrome: drugs, onset and neuromuscular signs

The neuromuscular examination is the strongest discriminator

Look at reflexes and muscle tone. Serotonin syndrome produces neuromuscular excitation: spontaneous or inducible clonus, ocular clonus, tremor and brisk reflexes, often more marked in the legs. Neuroleptic malignant syndrome produces severe generalised rigidity, sometimes with tremor that gives a cogwheel quality, and reflexes are often reduced rather than increased.

When a stem mentions clonus or hyperreflexia, think serotonin syndrome; when it describes stiff, rigid limbs that resist movement throughout, think NMS. Both syndromes can include some muscle stiffness, so read the whole picture rather than relying on the word rigid. The medication history then confirms the direction.

Mental state can differ too. Serotonin syndrome typically presents with agitation, restlessness and sometimes hallucinations alongside the twitching, jerking movements of clonus. NMS more often shows confusion developing alongside stiffness. These patterns help when a client takes medicines from both groups and the drug history alone is ambiguous.

Causative drugs and speed of onset

NMS follows drugs that reduce dopamine transmission. First- and second-generation antipsychotics are the classic cause, and dopamine-blocking antiemetics such as metoclopramide can also trigger it. Symptoms most often begin during the first two weeks of treatment, but they can occur after long-term use, and they typically develop over a day or more.

Serotonin syndrome follows increased serotonergic activity, commonly when two serotonergic agents are combined, for example an SSRI with tramadol, a triptan or an MAOI. It usually appears within 24 hours, and often within six hours, of starting a drug or changing a dose. Rapid onset after a recent medication change strongly favours serotonin syndrome.

Overlapping findings that cannot separate them

Both syndromes can cause hyperthermia, tachycardia, blood pressure swings, sweating and altered mental status. A raised temperature therefore confirms severity but not which syndrome is present. Many psychiatric clients take both antipsychotics and antidepressants, so the drug list alone may not settle it either.

Elevated creatine kinase is common in NMS because sustained rigidity damages muscle, and rhabdomyolysis can follow. Severe serotonin syndrome can also produce muscle injury. Laboratory results support assessment of complications, such as kidney injury and electrolyte disturbance, rather than acting as a single diagnostic test.

Shared first priority and different supportive treatments

For either syndrome, the first nursing action is to withhold the suspected drug and notify the prescriber urgently while assessing airway, breathing, circulation and temperature. Begin cooling measures as ordered, monitor vital signs closely, maintain fluids and track urine output and colour for signs of myoglobin.

Treatments then diverge under prescriber direction. Serotonin syndrome is managed with benzodiazepines for agitation and, if symptoms persist, the serotonin antagonist cyproheptadine. NMS may need intensive care, aggressive cooling and agents such as bromocriptine or dantrolene. Restraining a rigid or agitated client can worsen muscle breakdown and temperature, so follow protocol carefully.

Outlook also differs. With treatment, serotonin syndrome symptoms often settle within about a day, while NMS carries a meaningful risk of death even with intensive supportive care. Before any prescriber restarts an antipsychotic or serotonergic medicine, the reaction should be clearly documented as an adverse drug event.

Worked scenario: matching findings to the syndrome

A hypothetical client started tramadol for pain this morning while taking an SSRI. By evening she is agitated, sweating and febrile, with sustained ankle clonus. The options are NMS, serotonin syndrome, or an expected opioid adverse effect. Serotonin syndrome fits best because of the serotonergic combination, onset within hours and clonus.

Contrast a client ten days after starting haloperidol who has slowly become confused, febrile and rigid with reduced reflexes and a high creatine kinase. That picture points to NMS. In both cases the priority action is the same: hold the offending drug and escalate, rather than giving another dose of the suspect medicine.

Sources and further reading

MSD Manual Professional: Neuroleptic malignant syndrome. Dopamine-blocking causes, onset in the first two weeks, generalised rigidity, raised CK and supportive treatment.

MSD Manual Professional: Serotonin syndrome. Onset within 24 hours, clonus and hyperreflexia, differences from NMS, benzodiazepines and cyproheptadine.

MedlinePlus: Serotonin syndrome. Drug combinations that cause serotonin syndrome, rapid onset and stopping the offending medicines.